Want to see JP:4894 full AI Analyst Report?

Cuorips Inc. (4894) Price & Analysis

1 Followers

4894 Stock Chart & Stats

¥6230.00

¥25.00(0.51%)

At close: Jan 08 4:00 PM EST

¥6230.00

¥25.00(0.51%)

Day’s Range― - ―

52-Week Range¥3,610.00 - ¥12,400.00

Previous CloseN/A

Volume173.60K

Average Volume (3M)107.56K

Market Cap

¥34.11B

Enterprise Value¥28.63B

Total Cash (Recent Filing)¥3.90B

Total Debt (Recent Filing)¥0.00

Price to Earnings (P/E)―

Beta1.13

Next Earnings

Aug 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-124.55

Shares Outstanding8,274,576

10 Day Avg. Volume98,200

30 Day Avg. Volume107,556

Financial Highlights & Ratios

PEG Ratio-1.03

Price to Book (P/B)12.12

Price to Sales (P/S)271.07

P/FCF Ratio-52.19

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Zero DebtA zero-debt capital structure materially reduces interest expense risk and preserves financial flexibility. Over the next 2-6 months this durability supports continued R&D spending or strategic partnerships without immediate refinancing pressure, giving management room to execute operations.

Sizable Equity CushionA large equity base relative to assets provides a solvency buffer that can absorb continued operating losses and support near-term investment. This structural balance-sheet strength reduces bankruptcy risk and supports optionality for licensing, M&A, or staged R&D commitments.

Historical Revenue GrowthA positive historical revenue growth metric indicates prior product traction or market expansion capability. Despite recent setbacks, this suggests the company has demonstrated demand generation or commercialization skills that could be re-levered if cost control and execution improve.

Bears Say

Recent Revenue DeclineA near‑20% year-over-year revenue drop signals weakening market demand or execution issues. Sustained declines undermine scale economics, pressure gross margins and require either cost reduction or new revenue initiatives to stabilize the business over the medium term.

Widening Net LossesSubstantially larger annual losses erode retained equity and reduce internal funding capacity. Persistent deepening losses increase the likelihood of external financing, potential dilution, and limit the firm's ability to invest in commercial scale-up or long‑lead R&D projects without strategic support.

Accelerating Cash BurnWorsening negative free cash flow and cash burn ahead of accounting losses create an urgent funding requirement. This structural cash gap heightens refinancing risk and can force suboptimal financing or cuts to strategic programs, constraining durable growth prospects.

4894 FAQ

What was Cuorips Inc.’s price range in the past 12 months?

Cuorips Inc. lowest stock price was ¥3610.00 and its highest was ¥12400.00 in the past 12 months.

What is Cuorips Inc.’s market cap?

Cuorips Inc.’s market cap is ¥34.11B.

When is Cuorips Inc.’s upcoming earnings report date?

Cuorips Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 14 days.

How were Cuorips Inc.’s earnings last quarter?

Cuorips Inc. released its earnings results on May 15, 2026. The company reported -¥35.23 earnings per share for the quarter, missing the consensus estimate of N/A by -¥35.23.

Is Cuorips Inc. overvalued?

According to Wall Street analysts Cuorips Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cuorips Inc. pay dividends?

Cuorips Inc. does not currently pay dividends.

What is Cuorips Inc.’s EPS estimate?

Cuorips Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cuorips Inc. have?

Cuorips Inc. has 8,274,576 shares outstanding.

What happened to Cuorips Inc.’s price movement after its last earnings report?

Cuorips Inc. reported an EPS of -¥35.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.102%.

Which hedge fund is a major shareholder of Cuorips Inc.?

Currently, no hedge funds are holding shares in JP:4894

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Cuorips Inc.

Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.